Foreign investors who swore off China are edging back, and local signals say this is more than a short squeeze. Mainland media is documenting a steady return of northbound flows, policy firepower is obvious, and the AI-semiconductor complex is doing heavy lifting. The Shanghai Composite’s push to a decade high and Hong Kong’s four-year high are not just headline milestones; they are the product of a coordinated policy put and a targeted re-rating of domestic tech.
Securities Times flagged a visible shift in tone: “外资回流迹象明显，北向资金持续净买入” (signs of foreign capital returning are clear, with sustained net northbound buying). In parallel, Xinhua underscored Beijing’s policy stance after recent leadership meetings: “要用好逆周期和跨周期调节” (make good use of countercyclical and cross-cyclical adjustments). That framing matters. It signals that equity-market stabilization is now part of macro management, not merely market housekeeping. The data points align: global hedge funds saw their biggest monthly China buying in six months in August, while onshore chatter focuses on steady, not frenetic, foreign flows. Mainland brokers are steering clients toward AI, semiconductors, and high-end manufacturing as the clearest beneficiaries of the policy-designated innovation drive.
Indexes and sectors followed the script. The CSI 300 and Shanghai Composite extended gains, while the ChiNext and STAR Market outperformed on AI hardware, model training infrastructure, and components. In Hong Kong, the Hang Seng Tech Index led as platform names and local chip plays re-rated, helped by better liquidity and buyback commitments. A week of stimulus headlines earlier this year produced 3.3 percent to 11 percent jumps across the Shanghai, Shenzhen, and Hang Seng benchmarks, restoring roughly 1.8 trillion US dollars in market value. Taiwan and Korea tracked the theme, with semiconductors, memory, and AI server supply chains stronger, even as defensives lagged. Nikkei noted the rotation in the region as China-sensitive shares rallied: 中国関連株が主導 (China-linked stocks are taking the lead). In Korea, Maeil Business wrote of “중국 수혜 기대감” (rising expectations of China spillover) across battery materials and equipment. Sentiment has shifted from capitulation to cautious participation.
Beijing has expanded the policy toolkit in ways underappreciated outside China. The People’s Bank of China broadened a relending facility in January to support equity-market stabilization, including mechanisms that help listed companies finance buybacks and controlling shareholders increase stakes. Local coverage framed it plainly: 中国人民银行加大再贷款支持力度，支持上市公司回购与大股东增持 (the PBoC increased relending support to back buybacks and controlling shareholder increases). Regulators also leaned on the state balance sheet. State-backed funds, insurers, and brokerages were steered to add risk. Guidance to large life insurers to direct around 30 percent of new premiums into A-shares is a significant flow catalyst, not a headline flourish. Caixin captured the equity-policy crossover concisely: “证监会鼓励上市公司加大回购增持力度” (the CSRC encourages listed companies to step up buybacks and share increases). The resulting buyback wave and insider purchases create a supply-demand cushion that compounds the impact of northbound inflows.
This rally’s character is not property or banks; it is compute, components, and biopharma. Local tech press argues the AI chain is undergoing a valuation reset. Yicai reported: “DeepSeek带动AI全产业链估值重估” (DeepSeek has triggered a revaluation across the AI value chain), reflecting how a low-cost, high-performance model sharpened the market’s focus on domestic compute efficiency and model commercialization. Investors are pushing capital toward optical interconnects, power electronics, AI servers, and model infrastructure—areas where domestic substitution and export controls intersect in complex ways. Semiconductors remain constrained at the leading edge, but progress in packaging, memory, and specialty process nodes is supporting earnings. Biotech is joining the rotation on policy support for innovative drugs and accelerated approvals, with local media noting pipeline progress rather than just procurement headwinds. The throughline: innovation remains investable, even if the boundary conditions have shifted.
The growth impulse is softer than equity charts imply. Industrial output and retail sales disappointed in August, and foreign direct investment fell 13.2 percent in the first five months of 2025. Deflationary pressure is a live debate among local strategists, and stimulus is more surgical than splashy. Remember, Beijing already widened its deficit in late 2023 and approved an extra 1 trillion yuan of sovereign bonds to reinforce local investment. Economic Daily summarized the demand gap succinctly: “内需仍显不足，结构性压力未消” (domestic demand remains insufficient, structural pressures persist). That is why authorities are using balance-sheet channels—state funds, insurer allocations, buyback financing—to stabilize the equity transmission mechanism while broader demand repairs slowly. The trade-off is clear: support markets now to buy time for the economy.
Early movers are in. Hedge funds accelerated China buying in August, and allocators are reopening China mandates after a near-standstill last year. Emerging-market ex-China products have seen fewer launches, a sign that excluding China as a default hedge is losing momentum. Onshore, public mutual funds are rebuilding risk after a bruising 2023–2024, and broker research is rotating model portfolios toward AI plus high-end manufacturing. The onshore-offshore divide still matters: A-shares are less correlated to global factors and more sensitive to local policy and flows, while Hong Kong offers liquidity and entry points into platform economy names and ADR-returnees. Northbound connect data shows steady, not hot, foreign buying—consistent with a rerating phase rather than a melt-up.
Risks are not trivial. Property repair is partial, local-government debt remains a constraint, and deflation risks can sap margins. Governance questions—variable interest entities, data security, and audit access—still require position sizing discipline. But the equity-policy framework has evolved. Relending to enable buybacks and shareholder increases makes corporate balance sheets an active policy tool. Steering insurers and state funds formalizes an equity-allocations channel. Tightening around short-term speculative activity while encouraging strategic holding periods reduces volatility at the margin. In Chinese regulatory parlance, the aim is “稳预期、稳市场、稳增长” (stabilize expectations, markets, and growth). For portfolio construction, that means the downside distribution is less fat-tail than it was a year ago, even if the macro mean is lower.
English-language coverage tends to miss the plumbing: the way relending, insurer mandates, and state funds are being used to manufacture a bid beneath A-shares while the AI and semiconductor complex drives incremental earnings. The other miss is segmentation. Onshore is the diversification asset—low correlation, policy-sensitive, tech-weighted in the near term. Offshore Hong Kong is the liquidity sleeve. This is not an all-clear for China’s economy, and it is not a broad-market buy. It is a targeted rerating powered by a real policy backstop and a focused innovation cycle. If you need to diversify away from crowded US tech without losing the AI vector, China’s A-share supply chain and select Hong Kong tech offer that exposure—provided you underwrite policy mechanics and stick to cash-generative names with buyback capacity and verified domestic market share.
